The origin and application of experimental autoimmune encephalomyelitis
- PMID: 17917672
- DOI: 10.1038/nri2190
The origin and application of experimental autoimmune encephalomyelitis
Abstract
Experimental autoimmune encephalomyelitis (EAE) is a model of the neuroimmune system responding to priming with central nervous system (CNS)-restricted antigens. It is an excellent model of post-vaccinal encephalitis and a useful model of many aspects of multiple sclerosis. EAE has been established in numerous species and is induced by priming with a large number of CNS-derived antigens. As a consequence, the pathogenesis, pathology and clinical signs vary significantly between experimental protocols. As I describe in this Timeline article, the reductionist approach taken in some lines of investigation of EAE resulted in a reliance on results obtained under a narrow range of conditions. Although such studies made important contributions to our molecular understanding of inflammation, T-cell activation, and MHC restriction, they did not advance as effectively our knowledge of the polyantigenic responses that usually occur in CNS immunopathology and autoimmunity.
Similar articles
-
The role of CD8 suppressors versus destructors in autoimmune central nervous system inflammation.Hum Immunol. 2008 Nov;69(11):797-804. doi: 10.1016/j.humimm.2008.07.014. Epub 2008 Aug 22. Hum Immunol. 2008. PMID: 18723060 Review.
-
Neuropathic pain behaviours in a chronic-relapsing model of experimental autoimmune encephalomyelitis (EAE).Pain. 2009 Jan;141(1-2):156-64. doi: 10.1016/j.pain.2008.11.002. Epub 2008 Dec 11. Pain. 2009. PMID: 19084337
-
Soluble egg antigen from Schistosoma japonicum modulates the progression of chronic progressive experimental autoimmune encephalomyelitis via Th2-shift response.J Neuroimmunol. 2008 Feb;194(1-2):107-14. doi: 10.1016/j.jneuroim.2007.12.001. Epub 2008 Jan 22. J Neuroimmunol. 2008. PMID: 18207251
-
Surgical excision of CNS-draining lymph nodes reduces relapse severity in chronic-relapsing experimental autoimmune encephalomyelitis.J Pathol. 2009 Mar;217(4):543-51. doi: 10.1002/path.2476. J Pathol. 2009. PMID: 19023878
-
The translation of drug efficacy from in vivo models to human disease with special reference to experimental autoimmune encephalomyelitis and multiple sclerosis.Inflammopharmacology. 2007 Oct;15(5):183-7. doi: 10.1007/s10787-007-1607-z. Inflammopharmacology. 2007. PMID: 17943249 Review.
Cited by
-
Role of toll-like receptors in multiple sclerosis.Am J Clin Exp Immunol. 2013 Feb 27;2(1):75-93. Print 2013. Am J Clin Exp Immunol. 2013. PMID: 23885326 Free PMC article.
-
CNS-specific therapy for ongoing EAE by silencing IL-17 pathway in astrocytes.Mol Ther. 2012 Jul;20(7):1338-48. doi: 10.1038/mt.2012.12. Epub 2012 Mar 20. Mol Ther. 2012. PMID: 22434134 Free PMC article.
-
Regulatory T cells exert checks and balances on self tolerance and autoimmunity.Nat Immunol. 2010 Jan;11(1):7-13. doi: 10.1038/ni.1818. Epub 2009 Dec 17. Nat Immunol. 2010. PMID: 20016504 Review.
-
Role of nuclear factor κB in multiple sclerosis and experimental autoimmune encephalomyelitis.Neural Regen Res. 2018 Sep;13(9):1507-1515. doi: 10.4103/1673-5374.237109. Neural Regen Res. 2018. PMID: 30127103 Free PMC article. Review.
-
Efficient Distribution of a Novel Zirconium-89 Labeled Anti-cd20 Antibody Following Subcutaneous and Intravenous Administration in Control and Experimental Autoimmune Encephalomyelitis-Variant Mice.Front Immunol. 2019 Oct 18;10:2437. doi: 10.3389/fimmu.2019.02437. eCollection 2019. Front Immunol. 2019. PMID: 31681317 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials